文献速递甲状腺疾病

1988-2012年美国人群甲状腺功能障碍患病率趋势及其与死亡率的关联

Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该研究基于美国国家健康与营养调查(NHANES)III(1988-1994)、1999-2002和2007-2012三个周期共33117名12岁及以上参与者的横断面数据,估算甲状腺功能障碍的患病率及时间趋势,并分析其与死亡率的关联。2007-2012年亚临床和临床甲状腺功能减退症患病率分别为4.3%和0.33%,亚临床和临床甲状腺功能亢进症分别为3.2%和0.2%;80%的甲状腺功能障碍患者此前未被诊断。亚临床甲状腺功能障碍患病率保持稳定,而临床甲状腺功能减退症和亢进症患病率较1988-1994年下降。中位随访17.2年,任何类型甲状腺功能障碍与全因或心血管死亡风险均无显著关联;但在65岁及以上人群中,亚临床甲状腺功能减退症与全因死亡率(HR 1.17;95%CI 1.00-1.37;P=.05)和心血管死亡率(HR 1.29;95%CI 1.04-1.62;P=.02)升高相关。

要点

  • 2007-2012年亚临床甲状腺功能减退症患病率为4.3%,临床甲状腺功能减退症为0.33%。
  • 80%的甲状腺功能障碍患者此前未被诊断。
  • 65岁及以上人群中亚临床甲状腺功能减退症与全因死亡(HR 1.17;95%CI 1.00-1.37;P=.05)及心血管死亡(HR 1.29;95%CI 1.04-1.62;P=.02)风险升高相关。

核心结论

  • 亚临床甲状腺功能障碍患病率保持相对不变,而临床甲状腺功能障碍患病率下降。
  • 在65岁及以上人群中,亚临床甲状腺功能减退症与更高的全因死亡率和心血管死亡率相关。

研究设计与样本

  • 美国国家健康与营养调查(NHANES)III(1988-1994)、1999-2002和2007-2012三个周期的横断面分析,共纳入33117名12岁及以上参与者。

主要发现

  • 加权平均年龄为41.6岁,男性占48.3%。
  • 2007-2012年亚临床甲状腺功能减退症、临床甲状腺功能减退症、亚临床甲状腺功能亢进症和临床甲状腺功能亢进症的患病率分别为4.3%、0.33%、3.2%和0.2%。
  • 80%的甲状腺功能障碍患者此前未被诊断。
  • 亚临床甲状腺功能减退症和亚临床甲状腺功能亢进症患病率保持稳定,而临床甲状腺功能减退症(0.54% [95%CI 0.35-0.8] vs 0.33% [95%CI 0.23-0.48])和临床甲状腺功能亢进症(0.8% [95%CI 0.58-1.1] vs 0.2% [95%CI 0.12-0.33])在2007-2012年较1988-1994年患病率更低。
  • 中位随访17.2年,任何类型甲状腺功能障碍与全因死亡或心血管死亡风险均无显著关联。

关键数值与推荐

  • 在65岁及以上人群中,亚临床甲状腺功能减退症与全因死亡率升高相关(HR 1.17;95%CI 1.00-1.37;P=.05)。
  • 在65岁及以上人群中,亚临床甲状腺功能减退症与心血管死亡率升高相关(HR 1.29;95%CI 1.04-1.62;P=.02)。
  • 甲状腺功能减退症的危险因素包括年龄较大、美国白人、肥胖以及甲状腺过氧化物酶抗体和甲状腺球蛋白抗体阳性。
  • 甲状腺功能亢进症的危险因素包括年龄较大、女性以及美国黑人。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Various dynamic factors could influence the prevalence and distribution of thyroid dysfunction. OBJECTIVE: To provide national estimates and temporal trends in prevalence of thyroid dysfunction over the past 3 decades in United States and determine the impact of thyroid dysfunction on mortality in US adults. METHODS: A cross-sectional analysis of data from 33 117 participants aged 12 years or older in the National Health and Nutrition Examination Survey III (1988-1994), 1999-2002, and 2007-2012. RESULTS: The weighted mean age was 41.6 years, and 48.3% were men. In 2007 through 2012, the prevalence of subclinical and overt hypothyroidism, subclinical and overt hyperthyroidism was 4.3%, 0.33%, 3.2%, and 0.2% respectively. Eighty percent of individuals with thyroid dysfunction were previously undiagnosed. The prevalence of subclinical hypothyroidism and hyperthyroidism was stable, whereas overt hypothyroidism (0.54% [95% CI, 0.35-0.8] vs 0.33% [95% CI, 0.23-0.48]) and hyperthyroidism (0.8% [95% CI, 0.58-1.1] vs 0.2% [95% CI, 0.12-0.33]) were less prevalent in 2007-2012 compared to 1988-1994. Older age, White Americans, obesity, and positivity for thyroid peroxidase antibody and thyroglobulin antibody were risk factors for hypothyroidism, whereas older age, women, and Black Americans were risk factors for hyperthyroidism. Over a median follow-up of 17.2 years, no significant association was observed between any type of thyroid dysfunction with the risk of total or cardiovascular mortality. However, among individuals aged 65 years or older, subclinical hypothyroidism was associated with a higher risk of total mortality (hazard ratio, 1.17; 95% CI, 1.00-1.37; P = .05) and cardiovascular mortality (HR, 1.29; 95% CI, 1.04-1.62; P = .02). CONCLUSIONS: The prevalence of subclinical thyroid dysfunction remained relatively unchanged, whereas that of overt thyroid dysfunction decreased. Subclinical hypothyroidism was associated with a higher mortality among individuals aged 65 years or older.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhang X, Wang Y, Wang H, et al. Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012. J Clin Endocrinol Metab. 2024. PMID: 37738422. doi:10.1210/clinem/dgad558

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。